Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis

Craig D. Fisher, Jonathan P. Jackson, Andrew J. Lickteig, Lisa M. Augustine, Nathan J Cherrington

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Non-alcoholic steatohepatitis (NASH) is a disease that compromises hepatic function and the capacity to metabolize numerous drugs. Aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear factor-E2 related factor 2 (Nrf2) are xenobiotic activated transcription factors that regulate induction of a number of drug metabolizing enzymes (DMEs). The purpose of the current study was to determine whether experimental NASH alters the xenobiotic activation of these transcription factors and induction of downstream DME targets Cyp1A1, Cyp2B10, Cyp3A11, Cyp4A14 and NAD(P)H:quinone oxidoreductase 1 (Nqo1), respectively. Mice fed normal rodent chow or methionine-choline-deficient (MCD) diet for 8 weeks were then treated with microsomal enzyme inducers β-naphoflavone (BNF), 1,4-bis-[2-(3,5- dichloropyridyloxy)] benzene (TCPOBOP), pregnenolone-16α-carbonitrile (PCN), clofibrate (CFB) or oltipraz (OPZ), known activators of AhR, CAR, PXR, PPARα and Nrf2, respectively. Results of this study show that (1) Hepatic PXR mRNA levels were significantly increased (1.4-fold) in mice fed MCD diet, while AhR, CAR, PPARα and Nrf2 were not affected. (2) The MCD diet did not alter hepatic inducibility of Cyp1A1, Cyp2B10, Cyp3A11 mRNA levels by their respective microsomal inducers. (3) Constitutive levels of Cyp4A14 mRNA were significantly increased in mice fed the MCD diet, yet further induction by clofibrate was not observed. (4) Hepatic Nqo1 mRNA levels were significantly increased by the MCD diet; however, additional induction of Nqo1 was still achievable following treatment with the Nrf2 activator OPZ.

Original languageEnglish (US)
Pages (from-to)959-964
Number of pages6
JournalArchives of Toxicology
Volume82
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Enzyme Induction
NF-E2-Related Factor 2
Fatty Liver
Nutrition
Choline
Methionine
Aryl Hydrocarbon Receptors
PPAR alpha
Diet
Enzymes
Clofibrate
Messenger RNA
Pharmaceutical Preparations
Liver
Xenobiotics
Transcription Factors
Pregnenolone Carbonitrile
NAD
Rodentia
Oxidoreductases

Keywords

  • Cytochrome P450 enzymes and NAD(P)H:quinone oxidoreductase 1
  • Drug metabolizing enzyme induction
  • Non-alcoholic fatty liver disease
  • Xenobiotic activated receptors

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. / Fisher, Craig D.; Jackson, Jonathan P.; Lickteig, Andrew J.; Augustine, Lisa M.; Cherrington, Nathan J.

In: Archives of Toxicology, Vol. 82, No. 12, 12.2008, p. 959-964.

Research output: Contribution to journalArticle

Fisher, Craig D. ; Jackson, Jonathan P. ; Lickteig, Andrew J. ; Augustine, Lisa M. ; Cherrington, Nathan J. / Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. In: Archives of Toxicology. 2008 ; Vol. 82, No. 12. pp. 959-964.
@article{07fe0782f9d64ebeb800068ca7fee6db,
title = "Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis",
abstract = "Non-alcoholic steatohepatitis (NASH) is a disease that compromises hepatic function and the capacity to metabolize numerous drugs. Aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear factor-E2 related factor 2 (Nrf2) are xenobiotic activated transcription factors that regulate induction of a number of drug metabolizing enzymes (DMEs). The purpose of the current study was to determine whether experimental NASH alters the xenobiotic activation of these transcription factors and induction of downstream DME targets Cyp1A1, Cyp2B10, Cyp3A11, Cyp4A14 and NAD(P)H:quinone oxidoreductase 1 (Nqo1), respectively. Mice fed normal rodent chow or methionine-choline-deficient (MCD) diet for 8 weeks were then treated with microsomal enzyme inducers β-naphoflavone (BNF), 1,4-bis-[2-(3,5- dichloropyridyloxy)] benzene (TCPOBOP), pregnenolone-16α-carbonitrile (PCN), clofibrate (CFB) or oltipraz (OPZ), known activators of AhR, CAR, PXR, PPARα and Nrf2, respectively. Results of this study show that (1) Hepatic PXR mRNA levels were significantly increased (1.4-fold) in mice fed MCD diet, while AhR, CAR, PPARα and Nrf2 were not affected. (2) The MCD diet did not alter hepatic inducibility of Cyp1A1, Cyp2B10, Cyp3A11 mRNA levels by their respective microsomal inducers. (3) Constitutive levels of Cyp4A14 mRNA were significantly increased in mice fed the MCD diet, yet further induction by clofibrate was not observed. (4) Hepatic Nqo1 mRNA levels were significantly increased by the MCD diet; however, additional induction of Nqo1 was still achievable following treatment with the Nrf2 activator OPZ.",
keywords = "Cytochrome P450 enzymes and NAD(P)H:quinone oxidoreductase 1, Drug metabolizing enzyme induction, Non-alcoholic fatty liver disease, Xenobiotic activated receptors",
author = "Fisher, {Craig D.} and Jackson, {Jonathan P.} and Lickteig, {Andrew J.} and Augustine, {Lisa M.} and Cherrington, {Nathan J}",
year = "2008",
month = "12",
doi = "10.1007/s00204-008-0312-z",
language = "English (US)",
volume = "82",
pages = "959--964",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis

AU - Fisher, Craig D.

AU - Jackson, Jonathan P.

AU - Lickteig, Andrew J.

AU - Augustine, Lisa M.

AU - Cherrington, Nathan J

PY - 2008/12

Y1 - 2008/12

N2 - Non-alcoholic steatohepatitis (NASH) is a disease that compromises hepatic function and the capacity to metabolize numerous drugs. Aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear factor-E2 related factor 2 (Nrf2) are xenobiotic activated transcription factors that regulate induction of a number of drug metabolizing enzymes (DMEs). The purpose of the current study was to determine whether experimental NASH alters the xenobiotic activation of these transcription factors and induction of downstream DME targets Cyp1A1, Cyp2B10, Cyp3A11, Cyp4A14 and NAD(P)H:quinone oxidoreductase 1 (Nqo1), respectively. Mice fed normal rodent chow or methionine-choline-deficient (MCD) diet for 8 weeks were then treated with microsomal enzyme inducers β-naphoflavone (BNF), 1,4-bis-[2-(3,5- dichloropyridyloxy)] benzene (TCPOBOP), pregnenolone-16α-carbonitrile (PCN), clofibrate (CFB) or oltipraz (OPZ), known activators of AhR, CAR, PXR, PPARα and Nrf2, respectively. Results of this study show that (1) Hepatic PXR mRNA levels were significantly increased (1.4-fold) in mice fed MCD diet, while AhR, CAR, PPARα and Nrf2 were not affected. (2) The MCD diet did not alter hepatic inducibility of Cyp1A1, Cyp2B10, Cyp3A11 mRNA levels by their respective microsomal inducers. (3) Constitutive levels of Cyp4A14 mRNA were significantly increased in mice fed the MCD diet, yet further induction by clofibrate was not observed. (4) Hepatic Nqo1 mRNA levels were significantly increased by the MCD diet; however, additional induction of Nqo1 was still achievable following treatment with the Nrf2 activator OPZ.

AB - Non-alcoholic steatohepatitis (NASH) is a disease that compromises hepatic function and the capacity to metabolize numerous drugs. Aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), peroxisome proliferator-activated receptor alpha (PPARα), and nuclear factor-E2 related factor 2 (Nrf2) are xenobiotic activated transcription factors that regulate induction of a number of drug metabolizing enzymes (DMEs). The purpose of the current study was to determine whether experimental NASH alters the xenobiotic activation of these transcription factors and induction of downstream DME targets Cyp1A1, Cyp2B10, Cyp3A11, Cyp4A14 and NAD(P)H:quinone oxidoreductase 1 (Nqo1), respectively. Mice fed normal rodent chow or methionine-choline-deficient (MCD) diet for 8 weeks were then treated with microsomal enzyme inducers β-naphoflavone (BNF), 1,4-bis-[2-(3,5- dichloropyridyloxy)] benzene (TCPOBOP), pregnenolone-16α-carbonitrile (PCN), clofibrate (CFB) or oltipraz (OPZ), known activators of AhR, CAR, PXR, PPARα and Nrf2, respectively. Results of this study show that (1) Hepatic PXR mRNA levels were significantly increased (1.4-fold) in mice fed MCD diet, while AhR, CAR, PPARα and Nrf2 were not affected. (2) The MCD diet did not alter hepatic inducibility of Cyp1A1, Cyp2B10, Cyp3A11 mRNA levels by their respective microsomal inducers. (3) Constitutive levels of Cyp4A14 mRNA were significantly increased in mice fed the MCD diet, yet further induction by clofibrate was not observed. (4) Hepatic Nqo1 mRNA levels were significantly increased by the MCD diet; however, additional induction of Nqo1 was still achievable following treatment with the Nrf2 activator OPZ.

KW - Cytochrome P450 enzymes and NAD(P)H:quinone oxidoreductase 1

KW - Drug metabolizing enzyme induction

KW - Non-alcoholic fatty liver disease

KW - Xenobiotic activated receptors

UR - http://www.scopus.com/inward/record.url?scp=59849098860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849098860&partnerID=8YFLogxK

U2 - 10.1007/s00204-008-0312-z

DO - 10.1007/s00204-008-0312-z

M3 - Article

C2 - 18488193

AN - SCOPUS:59849098860

VL - 82

SP - 959

EP - 964

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

IS - 12

ER -